Owlet (OWLT) Cash from Financing Activities (2020 - 2026)
Owlet (OWLT) posted quarterly Cash from Financing Activities of $5.5 million for Q1 2026, up 171.2% year-over-year from $2.0 million in Q1 2025, and down 69.47% quarter-over-quarter from $17.9 million in Q4 2025.
Owlet (OWLT) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Owlet (OWLT) has reported Cash from Financing Activities for 7 consecutive years, with $5.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 171.2% year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $35.6 million (up 177.29% YoY), while the FY2025 annual figure was $32.1 million, up 100.17% from the prior year.
- Cash from Financing Activities retreated to $5.5 million in Q1 2026 per OWLT's latest filing, from $17.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $22.9 million in Q1 2023 and bottomed at -$4.4 million in Q3 2023.
- Historically, Cash from Financing Activities has averaged $4.8 million across 5 years, with a median of $3.0 million in 2023.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 321.79% — and 2025, when it jumped 2033.42%.
- Owlet's Cash from Financing Activities stood at -$2.0 million in 2022, then soared by 253.22% to $3.0 million in 2023, then plunged by 236.24% to -$4.1 million in 2024, then jumped by 538.21% to $17.9 million in 2025, then sank by 69.47% to $5.5 million in 2026.
- Business Quant data shows OWLT's Cash from Financing Activities at $5.5 million in Q1 2026, $17.9 million in Q4 2025, and $4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Owlet | 159.40 Mn | 122.85 Mn | 21.82 Mn | -3.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.43 Mn |
| Jun 30, 2026 | -3.43 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Sep 30, 2024 | 14.53 Mn |
| Sep 30, 2024 | 14.53 Mn |
| Jun 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 368,000.00 |
| Mar 31, 2024 | 5.23 Mn |
| Mar 31, 2024 | 5.23 Mn |